The Coca-Cola Company (KO) SEC Filings & Earnings Calls
EquiReason read 13 The Coca-Cola Company SEC filings in the last 12 months. Latest: 10-Q on 2026-07-29 — Coca-Cola reported Q2 2026 revenue of $13.38B (+7% YoY) and operating income of $4.67B (+9% YoY), with margin expansion and strong volume growth..
Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason
- Market cap
- 398.9B
- P/E TTM
- 27.8
- Dividend yield
- 2.2%
- 52-week
- —
- Next earnings
- 27 Oct, in 2 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
29 Jul 202610-QCoca-Cola reported Q2 2026 revenue of $13.38B (+7% YoY) and operating income of $4.67B (+9% YoY), with margin expansion and strong volume growth.earningsopen
Figures in the filing · each found in the filing text
| Net operating revenues · Q2-2026 | $13.38B | +7% y/y |
| Gross profit margin · Q2-2026 | 62.9% | |
| Operating margin · Q2-2026 | 34.9% | |
| Operating income · Q2-2026 | $4.67B | +9% y/y |
| Worldwide unit case volume growth · Q2-2026 | 5.0% | |
| Worldwide concentrate sales volume growth · Q2-2026 | 4.0% | |
| Advertising expenses · Q2-2026 | $1.56B | +18% y/y |
| Effective tax rate · Q2-2026 | 18.9% | |
| Net cash provided by operating activities · H1-2026 | $7.54B | -642% y/y |
| Capital expenditures · H1-2026 | $684M | -9% y/y |
Guidance
FX expected to favorably impact full year 2026 net operating revenues and operating income; concentrate sales volume growth expected to slightly lag unit case volume
Management expects FX tailwinds for the full year and sees concentrate volume growth slightly behind unit case volume.
Risks flagged
BodyArmor trademark impairment risk
“If the near-term operating results of this trademark do not achieve our revised financial projections, or if the macroeconomic conditions change, causing the discount rate to increase without an offsetting increase in the operating results, it is likely that we would be required to recognize an additional impairment charge.” · word for word
IRS tax litigation exposure
“The Company estimates that the potential aggregate remaining incremental tax and interest liability for the tax years 2010 through 2025 could be approximately $14 billion as of December 31, 2025.” · word for word
Ransomware event at fairlife
“the Company believes that the incident has not had, and is not reasonably likely to have, a material impact on the Company's financial condition or results of operations.” · word for word
28 Jul 20268-K · 2.02Net revenues $13.40B (+7% y/y); Global unit case volume growth 5; Operating margin 34.9; Guidance: Full year guidance raised; specific numbers not provided in excerpt.earningsopen
Figures in the filing · each found in the filing text
| Net revenues · Q2-2026 | $13.40B | +7% y/y |
| Global unit case volume growth · Q2-2026 | 5.0% | |
| Operating margin · Q2-2026 | 34.9% | |
| Comparable operating margin (Non-GAAP) · Q2-2026 | 35.6% | |
| EPS · Q2-2026 | $1.03 | +16% y/y |
| Comparable EPS (Non-GAAP) · Q2-2026 | $0.97 | +11% y/y |
| Year-to-date cash flow from operations · H1-2026 | $7.50B | |
| Year-to-date free cash flow (non-GAAP) · H1-2026 | $6.90B |
Guidance
Full year guidance raised; specific numbers not provided in excerpt.
Company raises full year guidance after strong Q2 results across revenue, margin, and EPS.
Risks flagged
Dynamic consumer landscape; input cost inflation partially offset by pricing.
“While we continue to see a dynamic consumer landscape... partially offset by higher input costs” · word for word
16 Jul 20268-K · 8.01Coca-Cola disclosed a ransomware incident at fairlife, its dairy subsidiary, resulting in unauthorized access to production systems and temporary suspension of U.S. production. Investigation ongoing; no material impact determined yet.open
Risks flagged
Operational disruption: fairlife U.S. production suspended; full scope and financial impact not yet determined.
“production operations at fairlife in the United States are temporarily suspended... The full scope, nature and impacts of the incident are not yet known.” · word for word
Cybersecurity risk: ransomware event may lead to remediation costs, potential data breach liability, and reputational damage.
“unauthorized access by a third party to a portion of its systems, including its production-related systems, in connection with a ransomware event.” · word for word
30 Apr 202610-QNet operating revenues $12.47B (+12% y/y); Unit case volume growth (worldwide) 3; Concentrate sales volume growth (worldwide) 8; Guidance: 2026 capex ~$2.2B, effective tax rate ~19.9%open
Figures in the filing · each found in the filing text
| Net operating revenues · Q1-2026 | $12.47B | +12% y/y |
| Unit case volume growth (worldwide) · Q1-2026 | 3.0% | |
| Concentrate sales volume growth (worldwide) · Q1-2026 | 8.0% | |
| Gross profit margin · Q1-2026 | 63.0% | |
| Operating margin · Q1-2026 | 35.0% | |
| Operating income · Q1-2026 | $4.36B | +19% y/y |
| Operating cash flow · Q1-2026 | $2.02B | |
| Capital expenditures · Q1-2026 | $266M | -14% y/y |
| BodyArmor trademark impairment · Q1-2026 | $960M | |
| Advertising expenses · Q1-2026 | $1.38B | +26% y/y |
Guidance
2026 capex ~$2.2B, effective tax rate ~19.9%
Management expects FX tailwind for full-year revenue and operating income; capex guided at ~$2.2B; effective tax rate ~19.9%.
Risks flagged
BodyArmor trademark impairment risk
“If the near-term operating results of this trademark do not achieve our revised financial projections, or if the macroeconomic conditions change, causing the discount rate to increase without an offsetting increase in the operating results, it is likely that we would be required to recognize an additional impairment charge.” · word for word
IRS tax litigation liability
“The Company estimates that the potential aggregate remaining incremental tax and interest liability for the tax years 2010 through 2025 could be approximately $14 billion as of December 31, 2025.” · word for word
Commodity cost pressure
“The increase was primarily due to the favorable impact of pricing initiatives and foreign currency exchange rate fluctuations, as well as the impact of the sale of our finished product operations in Nigeria, partially offset by higher commodity costs.” · word for word
28 Apr 20268-K · 2.02Coca-Cola Q1 2026: revenue +12% to $12.5B, organic +10%; EPS $0.91 (+18%); operating margin 35.0% vs 32.9%; raised full-year guidance; strong volume and price/mix growth.earningsopen
Figures in the filing · each found in the filing text
| Net Revenues · Q1-2026 | $12.50B | +12% y/y |
| Operating Margin · Q1-2026 | 35.0% | |
| Comparable Operating Margin (Non-GAAP) · Q1-2026 | 34.5% | |
| EPS · Q1-2026 | $0.91 | +18% y/y |
| Comparable EPS (Non-GAAP) · Q1-2026 | $0.86 | +18% y/y |
| Cash from Operations · Q1-2026 | $2.00B | |
| Free Cash Flow (Non-GAAP) · Q1-2026 | $1.80B | |
| Global Unit Case Volume Growth · Q1-2026 | 3.0% | |
| Concentrate Sales Growth · Q1-2026 | 8.0% |
Guidance
Full year 2026 organic revenue growth raised to 5-6% from 4-5%; comparable EPS growth raised to 4-6% from 3-5%
Coca-Cola raised full-year 2026 organic revenue and comparable EPS guidance, reflecting strong Q1 momentum and confidence in the balance of the year.
Risks flagged
Higher input costs and marketing investments partially offset margin expansion.
“partially offset by higher input costs and an increase in marketing investments” · word for word
Currency tailwinds may reverse; comparable EPS growth of 18% includes 3-point currency tailwind.
“comparable EPS (non-GAAP) performance included the impact of a 3-point currency tailwind” · word for word
16 Mar 2026DEF 14AProxy statement discloses CEO transition: James Quincey to become Executive Chairman, Henrique Braun to become CEO effective March 31, 2026, with separation of Chairman and CEO roles.open
Figures in the filing · each found in the filing text
| Net Operating Revenue Growth (organic, non-GAAP) · FY2025 | 5.0% | |
| Operating Income Growth (comparable currency neutral, non-GAAP, adjusted for structural changes) · FY2025 | 14.0% | |
| Earnings Per Share (EPS) · FY2025 | $3.04 | |
| Dividend per share increase · FY2026 | 3.9% | |
| Dividends returned to shareowners · FY2025 | $8.80B | |
| CEO Total Direct Compensation · FY2025 | $31M | |
| CEO Pay Ratio · FY2025 | $1739.00 | |
| Say-on-Pay Approval · FY2025 | 92.0% | |
| Berkshire Hathaway Ownership · 2025-12-31 | 9.3% | |
| Equity Burn Rate · FY2025 | 0.1% |
Guidance
Long-term growth plan: organic revenue growth 4% to 6%, comparable currency neutral operating income growth 6% to 8%
Incentive targets set at midpoint of long-term growth plan, indicating stable outlook.
Risks flagged
CEO Transition Execution Risk
“Effective March 31, 2026, Mr. Quincey will serve as Executive Chairman of the Board and Mr. Braun will serve as Chief Executive Officer of the Company.” · word for word
Sustainability Goal Achievement Risk
“For the 2023-2025 PSU program, Packaging was below the threshold performance level. Water was at the threshold performance level.”
Regulatory and Litigation Risk on Ingredients
“States are seeking to address the GRAS regulatory loophole by banning food chemicals that pose potential harm to human health. As of 2025, 20 states have introduced and/or passed legislation targeting food chemicals.” · word for word
20 Feb 20268-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen
Risks flagged
CEO transition is planned and orderly; low risk of disruption.
“Previously announced on December 10, 2025; Braun currently COO.”
20 Feb 202610-KUnit case volume (worldwide) 33,800,000,000 (+0% y/y); Unit case volume growth (EMEA) 3; Unit case volume growth (North America) -1open
Figures in the filing · each found in the filing text
| Unit case volume (worldwide) · FY2025 | 33,800,000,000 | 0% y/y |
| Unit case volume growth (EMEA) · EMEA · FY2025 | 3.0% | |
| Unit case volume growth (North America) · North America · FY2025 | -1.0% | |
| BodyArmor trademark impairment charge · FY2025 | $960M | |
| BodyArmor trademark remaining carrying value · FY2025 | $2.44B | |
| Net periodic pension cost (expected 2026) · FY2026 | $87M | -28% y/y |
Risks flagged
BodyArmor trademark further impairment risk
“If the near-term operating results of this trademark do not achieve our revised financial projections, or if the macroeconomic conditions change, causing the discount rate to increase without an offsetting increase in the operating results, it is likely that we would be required to recognize an additional impairment charge.” · word for word
Volume decline from price increases
“Higher product prices may result in reductions in sales volume. Consumers may be less willing to pay a price differential for our branded products and may increasingly purchase lower-priced offerings, or may forgo some purchases altogether.” · word for word
Weight-loss drug impact on demand
“the effects or perceived effects of the usage of weight-loss drugs on consumption patterns” · word for word
IRS tax dispute
“the United States Internal Revenue Service ("IRS") is seeking to increase our U.S. taxable income for tax years 2007 through 2009 by an amount that creates a potential additional U.S. federal income tax liability of approximately $3.3 billion for that period, plus interest.” · word for word
10 Feb 20268-K · 2.02Net Revenues $11.80B (+2% y/y); Net Revenues $47.90B (+2% y/y); Organic Revenues (Non-GAAP) Growth 5earningsopen
Figures in the filing · each found in the filing text
| Net Revenues · Q4-2025 | $11.80B | +2% y/y |
| Net Revenues · FY2025 | $47.90B | +2% y/y |
| Organic Revenues (Non-GAAP) Growth · Q4-2025 | 5.0% | |
| Organic Revenues (Non-GAAP) Growth · FY2025 | 5.0% | |
| Comparable EPS (Non-GAAP) · Q4-2025 | $0.58 | +6% y/y |
| Comparable EPS (Non-GAAP) · FY2025 | $3.00 | +4% y/y |
| Operating Margin · Q4-2025 | 15.6% | |
| Comparable Operating Margin (Non-GAAP) · Q4-2025 | 24.4% | |
| Comparable Operating Margin (Non-GAAP) · FY2025 | 31.2% | |
| Cash Flow from Operations · FY2025 | $7.40B |
Risks flagged
Currency headwinds impacting reported results; 9-point headwind on EPS in Q4, 8-point for FY.
“EPS performance included the impact of a 9-point currency headwind; EPS performance included the impact of an 8-point currency headwind” · word for word
Non-cash impairment charge of $960 million related to BODYARMOR trademark.
“non-cash impairment charge of $960 million related to the BODYARMOR trademark” · word for word
The Coca-Cola Company — questions
- What did The Coca-Cola Company file recently?
- 13 SEC filings in the last 12 months. Latest: 10-Q on 2026-07-29 — Coca-Cola reported Q2 2026 revenue of $13.38B (+7% YoY) and operating income of $4.67B (+9% YoY), with margin expansion and strong volume growth.
Every figure on this page comes from The Coca-Cola Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.